Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
about
STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis.Lipopolysaccharide Attenuates Induction of Proallergic Cytokines, Thymic Stromal Lymphopoietin, and Interleukin 33 in Respiratory Epithelial Cells Stimulated with PolyI:C and Human Parechovirus.Quercetin Inhibits LPS-Induced Inflammation and ox-LDL-Induced Lipid DepositionMicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.STAT5-Interacting Proteins: A Synopsis of Proteins that Regulate STAT5 Activity.Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases.Endothelial STAT3 Modulates Protective Mechanisms in a Mouse Ischemia-Reperfusion Model of Acute Kidney Injury.Lysophosphatidylcholine induces cytotoxicity/apoptosis and IL-8 production of human endothelial cells: Related mechanisms.JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.A Cell-Intrinsic Interferon-like Response Links Replication Stress to Cellular Aging Caused by Progerin.Inhibition of IRF8 Negatively Regulates Macrophage Function and Impairs Cutaneous Wound Healing.In silico epigenetics of metal exposure and subclinical atherosclerosis in middle aged men: pilot results from the Aragon Workers Health Study.Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry.Causes and consequences of genomic instability in laminopathies: replication stress and interferon response.Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs
P2860
Q33835025-49215C97-7D0D-4896-AB76-865D010CB370Q37363183-FF2D55BF-B814-4244-AB0C-963E87D3DCA6Q37622040-9C484A15-6F24-4AC0-85E7-CFF96B0FE999Q38699692-F8A789AE-7791-4A58-AE22-24AE3F14E141Q39175998-3FFD3442-D108-4C26-94BC-626E34DDED48Q39238946-9F8F73F8-19C2-4102-B6C6-FF7254BCA7E4Q47094984-42072BE2-2734-4D3C-A7C6-CA3C36A8FBF9Q47139910-CAFD0F03-57CF-423C-AD59-BC402C216EB1Q47439880-9074F66F-A62A-4B05-BDD3-0C5075DA54E3Q48556502-DB6590AE-780B-4E34-8B08-A90A774E162AQ50422448-EBBBE252-CB7B-477D-AD1B-EB80F0CDD3B8Q51425290-647239F8-4A2F-419F-BCB4-C40FA53E9442Q52568731-87637FA4-0185-4FC4-8F3F-589CC3199C25Q52653300-7F749018-0ECD-42E3-B504-2AD781970E96Q52720096-37680DAF-7EC9-4B75-9F8D-BEAAFC7FE8B0Q57072670-FDEF8C29-7DEF-4E0A-ACD9-7FDB7CB8790D
P2860
Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Targeted inhibition of STATs a ...... tegy in cardiovascular disease
@ast
Targeted inhibition of STATs a ...... tegy in cardiovascular disease
@en
Targeted inhibition of STATs a ...... tegy in cardiovascular disease
@nl
type
label
Targeted inhibition of STATs a ...... tegy in cardiovascular disease
@ast
Targeted inhibition of STATs a ...... tegy in cardiovascular disease
@en
Targeted inhibition of STATs a ...... tegy in cardiovascular disease
@nl
prefLabel
Targeted inhibition of STATs a ...... tegy in cardiovascular disease
@ast
Targeted inhibition of STATs a ...... tegy in cardiovascular disease
@en
Targeted inhibition of STATs a ...... tegy in cardiovascular disease
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Targeted inhibition of STATs a ...... tegy in cardiovascular disease
@en
P2093
Anna Piaszyk-Borychowska
Joanna Wesoly
Malgorzata Szelag
Martyna Plens-Galaska
P2860
P304
48788-48812
P3181
P356
10.18632/ONCOTARGET.9195
P407
P50
P5008
P577
2016-07-01T00:00:00Z